Role of NAD(P)H:quinone oxidoreductase (NQO1) in apoptosis induction by aziridinylbenzoquinones RH1 and MeDZQ

Acta Biochim Pol. 2005;52(4):937-41. Epub 2005 Jun 6.

Abstract

We aimed to characterize the role of NAD(P)H:quinone oxidoreductase (NQO1) in apoptosis induction by antitumour quinones RH1 (2,5-diaziridinyl-3-hydroxymethyl-6-methyl-1,4-benzoquinone) and MeDZQ (2,5-dimethyl-3,6-diaziridinyl-1,4-benzoquinone). Digitonin-permeabilized FLK cells catalyzed NADPH-dependent single- and two-electron reduction of RH1 and MeDZQ. At equitoxic concentrations, RH1 and MeDZQ induced apoptosis more efficiently than the nonalkylating duroquinone or H(2)O(2). The antioxidant N,N'-diphenyl-p-phenylene diamine, desferrioxamine, and the inhibitor of NQO1 dicumarol, protected against apoptosis induction by all compounds investigated, but to a different extent. The results of multiparameter regression analysis indicate that RH1 and MeDZQ most likely induce apoptosis via NQO1-linked formation of alkylating species but not via NQO1-linked redox cycling.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Apoptosis / physiology*
  • Aziridines / pharmacology*
  • Benzoquinones / pharmacology*
  • Cell Line, Tumor
  • Cytochromes c / drug effects
  • Cytochromes c / metabolism
  • NAD(P)H Dehydrogenase (Quinone) / metabolism*

Substances

  • 2,5-diaziridinyl-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone
  • Aziridines
  • Benzoquinones
  • Cytochromes c
  • NAD(P)H Dehydrogenase (Quinone)
  • NQO1 protein, human